| Mechanisms of action and rationale for the use of checkpoint inhibitors in cancer C Granier, E De Guillebon, C Blanc, H Roussel, C Badoual, E Colin, ... ESMO open 2 (2), e000213, 2017 | 287 | 2017 |
| XPO1 regulates erythroid differentiation and is a new target for the treatment of β-thalassemia F Guillem, M Dussiot, E Colin, T Suriyun, JB Arlet, N Goudin, G Marcion, ... Haematologica 105 (9), 2240, 2020 | 21 | 2020 |
| Multiplexed immunofluorescence analysis and quantification of intratumoral PD-1+ Tim-3+ CD8+ T cells C Granier, E Vinatier, E Colin, M Mandavit, C Dariane, V Verkarre, L Biard, ... JoVE (Journal of Visualized Experiments), e56606, 2018 | 19 | 2018 |
| Neuropilin-1 cooperates with PD-1 in CD8+ T cells predicting outcomes in melanoma patients treated with anti-PD1 J Rossignol, Z Belaid, G Fouquet, F Guillem, R Rignault, P Milpied, ... Iscience 25 (6), 2022 | 3 | 2022 |
| Adenosine signaling inhibits erythropoiesis and promotes myeloid differentiation M Mikdar, M Serra, E Colin, R Duval, EF Gautier, Y Lamarre, Y Colin, ... Haematologica 109 (1), 175, 2024 | 2 | 2024 |
| Biallelic mutations in the SARS2 gene presenting as congenital sideroblastic anemia E Colin, G Courtois, C Brouzes, J Pulman, M Rabant, A Rötig, H Taffin, ... haematologica 106 (12), 3202, 2021 | 2 | 2021 |
| Adenosine Signaling Perturbs Erythropoiesis and Promotes Myeloid Differentiation M Mikdar, M Serra, E Colin, YC Aronovicz, C Le Van Kim, T Peyrard, ... Blood 138, 1992, 2021 | | 2021 |
| Whole Exome Sequencing of a Patient with Atypical Congenital Pure Red Cell Aplasia Has Enabled the Identification of a Novel Key Actor of Erythropoiesis That May be Involved in … E Colin, G Courtois, L Da Costa, C Lefevre, M Dussiot, J Galimand, ... Blood 136, 3-4, 2020 | | 2020 |
